The Boardroom Illusion

Walk into any quarterly review meeting in any pharma company, and you'll likely see the same slide and storyline. It goes something like this:

Commercial reports 80,000 email opens, 3,000 landing page visits, and a click-through rate up 12% from last quarter. The room nods. Someone circles the green number. And nobody in the room can tell you whether any of it changed how one doctor prescribes.

That dashboard does exactly what it was built to do: prove activity happened. Proving that something changed was never in the specification.

Commercial at least argues about which clicks matter. Medical Affairs is a decade behind. MSL meeting counts. Congress booth footfall. Slide-deck delivery numbers. Count the scientific exchanges, and you have an attendance register, but it's basically nothing more.

Nobody would accept "we held the meeting" as proof that a trial worked. Yet, we accept it every quarter as proof that an engagement strategy worked.

A metric is a number: clicks, meetings, downloads, impressions. A KPI is a number tied to a target that shows a shift in attitude, knowledge, or clinical practice. We argue that most pharma dashboards treat the two as interchangeable.

We see the same pattern in audit after audit: a genuinely capable data and visualisation stack sitting on top of a KPI framework that was designed years ago to prove a campaign happened, not to prove it worked. An outcome-linked KPI is harder to report than an activity metric, so most organisations default to the easy number and buy better software to display it.

This failure hits the budget. When measurement can't separate signal from noise, budget follows the noise. We've seen organisations spend seven figures a year on channels and segments that never drove prescribing behaviour in the first place.

Fixing it takes more than a new report. It means rebuilding the measurement architecture from the ground up: start with the clinical or commercial behaviour you need to shift, then decide what's worth tracking along the way. Vanity metrics don't survive that exercise. Nor do most current dashboards.

So stop asking how much activity you generated. Ask who engaged and what changed. If your board can't answer the second question, nobody in the room can see your ROI, and the dashboard makes that harder to notice.

Impact measurement is a foundation, not a reporting layer. Get it wrong, and segmentation, journeys and operating model are all being steered by the wrong signal.

If that second question gave you pause, it's usually worth a proper look. Comment or DM the word KPI, and we'll send our one-page Structural Comparison Tool. Or skip the download, DM us, and we'll put your own dashboard under the same lens.

Read and discuss this article on LinkedIn